Automated Nucleic Acid Amplification and Purification at Point of Need
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid production workflows for medical therapeutics are labor-intensive, generate significant chemical waste, and require centralized facilities, making them inefficient and unsuitable for rapid deployment at points of need, while also necessitating protein removal to meet high-quality standards.
Innovation Solution
A system and method for automated nucleic acid synthesis and purification that includes real-time monitoring and a functionally closed process, utilizing modules for amplification and purification, with sensors and controllers to ensure quality and quantity, and rehydration of lyophilized reagents for efficient production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If manual labor intensive steps are used in current workflows, then flexibility and adaptability are improved, but productivity and time efficiency deteriorate
Solution Approach 1:
The system performs self-monitoring and self-regulation through automated sensors that detect reaction parameters (pH, temperature, pressure, optical density) and automatically adjust conditions without human intervention, enabling both high productivity and adaptability through intelligent automation
Solution Approach 2:
Manual mechanical operations are replaced with automated electronic control systems, sensors, and computerized monitoring that can rapidly respond to process changes, simultaneously improving production speed while maintaining workflow flexibility through programmable control
2Manufacturing precision
If centralized GMP facilities are used, then manufacturing precision and quality control are improved, but loss of time and deployment speed deteriorate
Solution Approach 1:
The centralized manufacturing process is segmented into modular automated units that can be deployed distributively at point-of-need locations, with each module containing essential functions (amplification, purification, formulation) to maintain quality control independently while reducing deployment time
Solution Approach 2:
The system maintains GMP-quality manufacturing precision by implementing real-time automated monitoring of critical parameters (temperature, pH, pressure, optical density) and adjusting conditions dynamically, enabling high-quality production in distributed locations without requiring centralized facilities
3Manufacturing precision
If functionally closed system is implemented, then purity and contamination control are improved, but device complexity increases
Solution Approach 1:
Multiple functions (amplification, purification, formulation, monitoring) are merged into an integrated automated system with unified control, reducing operational complexity while maintaining closed-system purity through coordinated execution of combined processes
Solution Approach 2:
Automated robotic arms and transfer mechanisms serve as intermediaries that physically connect different modules while maintaining sterile barriers and closed-system integrity, enabling complex multi-step processes without direct human contact that would compromise purity
4Measurement precision
If real-time inline monitoring is performed, then measurement precision and quality control are improved, but use of energy and device complexity increase
Solution Approach 1:
Monitoring is performed continuously throughout the reaction process rather than through discrete sampling, allowing early detection of deviations and optimized energy usage by maintaining stable conditions through real-time feedback control
Solution Approach 2:
Sensors provide real-time feedback on reaction parameters (pH, temperature, pressure, optical density) that is automatically processed to adjust process conditions, improving measurement precision while optimizing energy consumption through intelligent control algorithms
Data Source
AI summary
A system includes a nucleic acid amplification module configured to receive deoxyribonucleic acid (DNA) template and to generate a nucleic acid product from the DNA template utilizing an amplification reaction while performing real-time inline monitoring of the amplification reaction via a plurality of sensors. The system also includes a purification module configured to purify the nucleic acid product. The nucleic acid amplification module and the purification module are each automated and form a functionally closed system.


